BEST UNLIMITED TURBO LONG CERTIFICATE - AMGEN | Market Closed - Euronext Paris 17:30:00 02/05/2024 BST | ||
| 10.79 EUR | +1.19% |
|
| Current month | +1.42% | ||
| 1 month | -1.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/05/24 | 10.79 | +1.19% | 75 |
| 30/04/24 | 10.66 | +0.82% | 82 |
| 29/04/24 | 10.58 | +3.38% | 85 |
| 26/04/24 | 10.23 | +1.67% | 77 |
| 25/04/24 | 10.06 | -5.44% | 85 |
Real-time Euronext Paris
Last update May 02, 2024 at 05:30 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| NR77S | |
| ISIN | DE000SF45MG3 |
| Date issued | 29/09/2021 |
| Strike | 162.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.16 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.92 € |
|---|---|
| Lowest since issue | 5.083 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
277.4
USD
Average target price
302.9
USD
Spread / Average Target
+9.20%
- Stock Market
- Certificates
- NR77S Certificat
